최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Frontiers in cell and developmental biology, v.8, 2020년, pp.587866 -
Kassem, Dina H. (Department of Biochemistry, Faculty of Pharmacy, Ain Shams University , Cairo , Egypt) , Kamal, Mohamed M. (Department of Biochemistry, Faculty of Pharmacy, Ain Shams University , Cairo , Egypt)
Corona virus disease 2019 (COVID-19) is a global public health crisis. The high infectivity of the disease even from non-symptomatic infected patients, together with the lack of a definitive cure or preventive measures are all responsible for disease outbreak. The severity of COVID-19 seems to be mo...
Alcayaga-Miranda F. Cuenca J. Khoury M. ( 2017 ). Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies. Front. Immunol. 8 : 339 . 10.3389/fimmu.2017.00339 28424688
Allegra A. Di Gioacchino M. Tonacci A. Musolino C. Gangemi S. ( 2020 ). Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications. Int. J. Mol. Sci. 21 : 4782 . 10.3390/ijms21134782 32640747
Arabi Y. M. Mandourah Y. Al-Hameed F. Sindi A. A. Almekhlafi G. A. Hussein M. A. ( 2018 ). Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome. Am. J. Respir. Crit. Care Med. 197 757 ? 767 . 29161116
Armitage J. Tan D. B. A. Troedson R. Young P. Lam K.-V. Shaw K. ( 2018 ). Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study. Eur. Respir. J. 51 : 1702369 . 10.1183/13993003.02369-2017 29348155
Atluri S. Manchikanti L. Hirsch J. A. ( 2020 ). Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ILL COVID-19 patients: the case for compassionate use. Pain Physician 23 E71 ? E84 . 32214286
Bari E. Ferrarotti I. Torre M. L. Corsico A. G. Perteghella S. ( 2019 ). Mesenchymal stem/stromal cell secretome for lung regeneration: the long way through “pharmaceuticalization” for the best formulation. J. Control. Release 309 11 ? 24 . 10.1016/j.jconrel.2019.07.022 31326462
Barrett A. N. Fong C.-Y. Subramanian A. Liu W. Feng Y. Choolani M. ( 2018 ). Human Wharton’s jelly mesenchymal stem cells show unique gene expression compared with bone marrow mesenchymal stem cells using single-cell RNA-sequencing. Stem Cells Dev. 28 196 ? 211 . 10.1089/scd.2018.0132 30484393
Baruah V. Bose S. ( 2020 ). Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J. Med. Virol. 92 495 ? 500 . 10.1002/jmv.25698 32022276
Basalova N. Sagaradze G. Arbatskiy M. Evtushenko E. Kulebyakin K. Grigorieva O. ( 2020 ). Secretome of mesenchymal stromal cells prevents myofibroblasts differentiation by transferring fibrosis-associated microRNAs within extracellular vesicles. Cells 9 : 1272 . 10.3390/cells9051272 32443855
Beigel J. H. Tomashek K. M. Dodd L. E. Mehta A. K. Zingman B. S. Kalil A. C. ( 2020 ). Remdesivir for the treatment of covid-19 ― preliminary report. N. Engl. J. Med. 10.1056/NEJMoa2007764 [Epub ahead of print] . 32445440
Bjorge I. M. Kim S. Y. Mano J. F. Kalionis B. Chrzanowski W. ( 2018 ). Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair. Biomater. Sci. 6 60 ? 78 . 10.1039/c7bm00479f 29184934
Borger V. Weiss D. J. Anderson J. D. Borras F. E. Bussolati B. Carter D. R. F. ( 2020 ). International society for extracellular vesicles and international society for cell and gene therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy 22 482 ? 485 . 10.1016/j.jcyt.2020.05.002 32425691
Chen G. Chen D. Z. Li J. Czura C. J. Tracey K. J. Sama A. E. ( 2004 ). Pathogenic role of HMGB1 in SARS? Med. Hypotheses 63 691 ? 695 . 10.1016/j.mehy.2004.01.037 15325019
Chen G. Wu D. Guo W. Cao Y. Huang D. Wang H. ( 2020 ). Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130 2620 ? 2629 . 10.1172/jci137244 32217835
Chen L. Liu H. G. Liu W. Liu J. Liu K. Shang J. ( 2020 ). [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 43 : E005 .
Chinese Clinical Trial Registry ( 2020 ). Available online at: http://www.chictr.org.cn (accessed June 26, 2020) .
ClinicalTrials.gov ( 2020 ). Available online at: https://clinicaltrials.gov/ (accessed September 6, 2020) .
Cruz F. F. Rocco P. R. M. ( 2020 ). The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev. Respir. Med. 14 31 ? 39 . 10.1080/17476348.2020.1679628 31608724
Derkus B. Emregul K. C. Emregul E. ( 2017 ). A new approach in stem cell research-exosomes: their mechanism of action via cellular pathways. Cell Biol. Int. 41 466 ? 475 . 10.1002/cbin.10742 28191696
Deshmukh V. Tripathi S. C. Pandey A. Deshmukh V. Vykoukal J. Patil A. ( 2020 ). CoviD-19: a conundrum to decipher. Eur. Rev. Med. Pharmacol. Sci. 24 5830 ? 5841 . 32495923
Deshpande C. ( 2020 ). Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism? Ann. Int. Med. 10.7326/M20-3255 [Epub ahead of print] . 32422061
Devaney J. Horie S. Masterson C. Elliman S. Barry F. O’Brien T. ( 2015 ). Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 70 625 ? 635 . 10.1136/thoraxjnl-2015-206813 25986435
El Andaloussi S. Mager I. Breakefield X. O. Wood M. J. ( 2013 ). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 347 ? 357 . 10.1038/nrd3978 23584393
El Omar R. Beroud J. Stoltz J. Menu P. Velot E. Decot V. ( 2014 ). Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell based therapies? Tissue Eng. Part B Rev. 20 523 ? 544 . 10.1089/ten.teb.2013.0664 24552279
Fong C. Chak L. Biswas A. Tan J. Gauthaman K. Chan W. ( 2011 ). Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. Rep. 7 1 ? 16 . 10.1007/s12015-010-9166-x 20602182
Gao F. Chiu S. M. Motan D. A. L. Zhang Z. Chen L. Ji H. L. ( 2016 ). Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 7 : e2062 . 10.1038/cddis.2015.327 26794657
Gao J. Tian Z. Yang X. ( 2020 ). Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends 14 72 ? 73 . 10.5582/bst.2020.01047 32074550
Gao Y. Li T. Han M. Li X. Wu D. Xu Y. ( 2020 ). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 92 791 ? 796 . 10.1002/jmv.25770 32181911
Giri J. Galipeau J. ( 2020 ). Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv. 4 1987 ? 1997 . 10.1182/bloodadvances.2020001711 32384543
Golchin A. Seyedjafari E. Ardeshirylajimi A. ( 2020 ). Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev. Rep. 16 427 ? 433 . 10.1007/s12015-020-09973-w 32281052
Gorbalenya A. E. Baker S. C. Baric R. S. de Groot R. J. Drosten C. Gulyaeva A. A. ( 2020 ). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5 536 ? 544 . 10.1038/s41564-020-0695-z 32123347
Group T. R. C. ( 2020 ). Dexamethasone in hospitalized patients with Covid-19 ― preliminary report. N. Engl. J. Med. 10.1056/NEJMoa2021436 [Epub ahead of print] . 32678530
Han P. L. Pang T. Diao K. Y. Yang Z. G. ( 2020 ). Corona virus disease 2019 (COVID-19): the image tells the truth. Infection 10.1007/s15010-020-01431-6 [Epub ahead of print] . 32385842
Harrell C. R. Sadikot R. Pascual J. Fellabaum C. Jankovic M. G. Jovicic N. ( 2019 ). Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives. Stem Cells Int. 2019 : 4236973 .
Henderson L. A. Canna S. W. Schulert G. S. Volpi S. Lee P. Y. Kernan K. F. ( 2020 ). On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 72 1059 ? 1063 . 32293098
Hoffmann M. Kleine-Weber H. Pohlmann S. ( 2020 ). A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78 779 ? 784.e5 . 32362314
Hu S. Park J. Liu A. Lee J. Zhang X. Hao Q. ( 2018 ). Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells. Stem Cells Transl. Med. 7 615 ? 624 . 10.1002/sctm.17-0278 29737632
Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. ( 2020 ). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 497 ? 506 . 31986264
Johnson R. M. Vinetz J. M. ( 2020 ). Dexamethasone in the management of covid -19. BMJ 370 : m2648 . 10.1136/bmj.m2648 32620554
Kamal M. M. Kassem D. H. ( 2020 ). Therapeutic potential of Wharton’s jelly mesenchymal stem cells for diabetes: achievements and challenges. Front. Cell Dev. Biol. 8 : 16 . 10.3389/fcell.2020.00016 32064260
Khoury M. Cuenca J. Cruz F. F. Figueroa F. E. Rocco P. R. M. Weiss D. J. ( 2020 ). Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur. Respir. J. 55 : 2000858 . 10.1183/13993003.00858-2020 32265310
Kindler E. Thiel V. ( 2016 ). SARS-CoV and IFN: too little, too late. Cell Host Microbe 19 139 ? 141 . 10.1016/j.chom.2016.01.012 26867172
Land W. G. ( 2020 ). Use of DAMPs and SAMPs as therapeutic targets or therapeutics: a note of caution. Mol. Diagn. Ther. 24 251 ? 262 . 10.1007/s40291-020-00460-z 32248387
Lee J. W. Krasnodembskaya A. McKenna D. H. Song Y. Abbott J. Matthay M. A. ( 2013 ). Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am. J. Respir. Crit. Care Med. 187 751 ? 760 . 10.1164/rccm.201206-0990oc 23292883
Leiva-Juarez M. M. Kolls J. K. Evans S. E. ( 2018 ). Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol. 11 21 ? 34 . 10.1038/mi.2017.71 28812547
Leng Z. Zhu R. Hou W. Feng Y. Yang Y. Han Q. ( 2020 ). Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia. Aging Dis. 11 216 ? 228 . 10.14336/ad.2020.0228 32257537
Li H. Liu S. M. Yu X. H. Tang S. L. Tang C. K. ( 2020 ). Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents 55 : 105951 .
Liu X. Feng T. Gong T. Shen C. Zhu T. Wu Q. ( 2015 ). Human umbilical cord mesenchymal stem cells inhibit the function of allogeneic activated Vγ9Vδ2 T lymphocytes in vitro. Biomed Res. Int. 2015 : 317801 .
Liu Z. Long W. Tu M. Chen S. Huang Y. Wang S. ( 2020 ). Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J. Infect. 81 318 ? 356 . 10.1016/j.jinf.2020.03.054 32283159
Ma S. Xie N. Li W. Yuan B. Shi Y. Wang Y. ( 2014 ). Immunobiology of mesenchymal stem cells. Cell Death Differ. 21 216 ? 225 . 24185619
Mahase E. ( 2020 ). Covid-19: demand for dexamethasone surges as RECOVERY trial publishes preprint. BMJ 369 : m2512 . 10.1136/bmj.m2512 32576548
Malcherek G. Jin N. Huckelhoven A. G. Mani J. Wang L. Gern U. ( 2014 ). Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells. Leukemia 28 2388 ? 2394 . 10.1038/leu.2014.273 25227910
Matthay M. A. ( 2015 ). Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Ann. Am. Thorac. Soc. 12 ( Suppl. 1 ), S54 ? S57 . 25830837
Mehta P. McAuley D. F. Brown M. Sanchez E. Tattersall R. S. Manson J. J. ( 2020 ). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395 1033 ? 1034 . 10.1016/s0140-6736(20)30628-0 32192578
Meng F. Xu R. Wang S. Xu Z. Zhang C. Li Y. ( 2020 ). Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct. Target. Ther. 5 : 172 .
Meselson M. ( 2020 ). Droplets and aerosols in the transmission of SARS-CoV-2. N. Engl. J. Med. 382 : 2063 . 10.1056/nejmc2009324 32294374
Moll G. Ankrum J. A. Kamhieh-Milz J. Bieback K. Ringden O. Volk H.-D. ( 2019 ). Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol. Med. 25 149 ? 163 . 10.1016/j.molmed.2018.12.006 30711482
Moll G. Drzeniek N. Kamhieh-Milz J. Geissler S. Volk H. D. Reinke P. ( 2020 ). MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy. Front. Immunol. 11 : 1091 . 10.3389/fimmu.2020.01091 32574263
Nelemans T. Kikkert M. ( 2019 ). Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses 11 : 961 . 10.3390/v11100961 31635238
Newton W. C. Kim J. W. Luo J. Z. Q. Luo L. ( 2017 ). Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy. J. Mol. Endocrinol. 59 R155 ? R165 . 28835418
Okabayashi T. Kariwa H. Yokota S. Iki S. Indoh T. Yokosawa N. ( 2006 ). Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J. Med. Virol. 78 417 ? 424 . 10.1002/jmv.20556 16482545
Ortiz L. A. Gambelli F. McBride C. Gaupp D. Baddoo M. Kaminski N. ( 2003 ). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U.S.A. 100 8407 ? 8411 . 10.1073/pnas.1432929100 12815096
Perrotta F. Matera M. G. Cazzola M. Bianco A. ( 2020 ). Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter? Respir. Med. 168 : 105996 . 10.1016/j.rmed.2020.105996 32364961
Pittenger M. F. Discher D. E. Peault B. M. Phinney D. G. Hare J. M. Caplan A. I. ( 2019 ). Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 4 : 22 .
Qin C. Zhou L. Hu Z. Zhang S. Yang S. Tao Y. ( 2020 ). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71 762 ? 768 . 10.1093/cid/ciaa248 32161940
Rajarshi K. Chatterjee A. Ray S. ( 2020 ). Combating COVID-19 with mesenchymal stem cell therapy. Biotechnol. Rep. 26 : e00467 . 10.1016/j.btre.2020.e00467 32420049
Rolandsson Enes S. Weiss D. J. ( 2020 ). Cell therapy for lung disease: current status and future prospects. Curr. Stem Cell Rep. 6 30 ? 39 . 10.1007/s40778-020-00171-5
Ruan Q. Yang K. Wang W. Jiang L. Song J. ( 2020 ). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46 846 ? 848 . 10.1007/s00134-020-05991-x 32125452
Russell B. Moss C. George G. Santaolalla A. Cope A. Papa S. ( 2020 ). Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 14 : 1022 .
Savukinas U. B. Enes S. R. Sjoland A. A. Westergren-Thorsson G. ( 2016 ). Concise review: the bystander effect: mesenchymal stem cell-mediated lung repair. Stem Cells 34 1437 ? 1444 . 10.1002/stem.2357 26991735
Shang J. Wan Y. Luo C. Ye G. Geng Q. Auerbach A. ( 2020a ). Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 117 11727 ? 11734 . 32376634
Shang J. Ye G. Shi K. Wan Y. Luo C. Aihara H. ( 2020b ). Structural basis of receptor recognition by SARS-CoV-2. Nature 581 221 ? 224 . 10.1038/s41586-020-2179-y 32225175
Shetty P. Cooper K. Viswanathan C. ( 2010 ). Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J. Transfus. Sci. 4 14 ? 24 . 10.4103/0973-6247.59386 20376261
Shi Y. Wang Y. Shao C. Huang J. Gan J. Huang X. ( 2020 ). COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 27 1451 ? 1454 . 10.1038/s41418-020-0530-3 32205856
Shin D. Mukherjee R. Grewe D. Bojkova D. Baek K. Bhattacharya A. ( 2020 ). Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 10.1038/s41586-020-2601-5 [Epub ahead of print] . 32726803
Silachev D. N. Goryunov K. V. Shpilyuk M. A. Beznoschenko O. S. Morozova N. Y. Kraevaya E. E. ( 2019 ). Effect of MSCs and MSC-derived extracellular vesicles on human blood coagulation. Cells 8 : 258 . 10.3390/cells8030258 30893822
Silva J. D. de Castro L. L. Braga C. L. Oliveira G. P. Trivelin S. A. Barbosa-Junior C. M. ( 2019 ). Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology. Stem Cells Int. 2019 : 8262849 .
Taghavi-Farahabadi M. Mahmoudi M. Soudi S. Hashemi S. M. ( 2020 ). Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Med. Hypotheses 144 : 109865 . 10.1016/j.mehy.2020.109865 32562911
Taghdiri N. V. Soura M. Aliakbar Y. A. Amir A. Mehrnaz I. Fatemeh D. ( 2018 ). The extracellular vesicles-derived from mesenchymal stromal cells: a new therapeutic option in regenerative medicine. J. Cell. Biochem. 119 8048 ? 8073 . 10.1002/jcb.26726 29377241
Tang D. Comish P. Kang R. ( 2020 ). The hallmarks of COVID-19 disease. PLoS Pathog. 16 : e1008536 . 10.1371/journal.ppat.1008536 32442210
Tang D. Kang R. Coyne C. B. Zeh H. J. Lotze M. T. ( 2012 ). PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 249 158 ? 175 . 10.1111/j.1600-065x.2012.01146.x 22889221
Tay M. Z. Poh C. M. Renia L. MacAry P. A. Ng L. F. P. ( 2020 ). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20 363 ? 374 . 10.1038/s41577-020-0311-8 32346093
Teijaro J. R. Walsh K. B. Rice S. Rosen H. Oldstone M. B. ( 2014 ). Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 111 3799 ? 3804 . 10.1073/pnas.1400593111 24572573
van Doremalen N. Bushmaker T. Morris D. H. Holbrook M. G. Gamble A. Williamson B. N. ( 2020 ). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382 1564 ? 1567 . 32182409
Velazquez-Salinas L. Verdugo-Rodriguez A. Rodriguez L. L. Borca M. V. ( 2019 ). The role of interleukin 6 during viral infections. Front. Microbiol. 10 : 1057 . 10.3389/fmicb.2019.01057 31134045
Wang J. Jiang M. Chen X. Montaner L. J. ( 2020 ). Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 108 17 ? 41 . 10.1002/jlb.3covr0520-272r 32534467
Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. ( 2020 ). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30 269 ? 271 . 10.1038/s41422-020-0282-0 32020029
Waterman R. S. Tomchuck S. L. Henkle S. L. Betancourt A. M. ( 2010 ). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 5 : e10088 . 10.1371/journal.pone.0010088 20436665
Weiss A. R. R. Dahlke M. H. ( 2019 ). Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front. Immunol. 10 : 1191 . 10.3389/fimmu.2019.01191 31214172
Weiss M. L. Anderson C. Medicetty S. Seshareddy K. B. Weiss R. J. VanderWerff I. ( 2008 ). Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells 26 2865 ? 2874 . 10.1634/stemcells.2007-1028 18703664
Witkowski M. Landmesser U. Rauch U. ( 2016 ). Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc. Med. 26 297 ? 303 . 10.1016/j.tcm.2015.12.001 26877187
World Health Organization [WHO] ( 2020a ). World Health Organization Media Center. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed September 10, 2020) .
World Health Organization [WHO] ( 2020b ). World Health Organization Media Center. Available at: https://www.who.int/westernpacific/emergencies/covid-19/information/high-risk-groups (accessed September 6, 2020) .
Xu H. Zhong L. Deng J. Peng J. Dan H. Zeng X. ( 2020 ). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12 : 8 .
Yang M. Cao L. Xie M. Yu Y. Kang R. Yang L. ( 2013 ). Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem. Pharmacol. 86 410 ? 418 . 10.1016/j.bcp.2013.05.013 23707973
Yen B. L. Yen M. L. Wang L. T. Liu K. J. Sytwu H. K. ( 2020 ). Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: gleaning insights for possible use in COVID-19. Stem Cells Transl. Med. 10.1002/sctm.20-0186 [Epub ahead of print] . 32526079
Zaim S. Chong J. H. Sankaranarayanan V. Harky A. ( 2020 ). COVID-19 and multiorgan response. Curr. Probl. Cardiol. 45 : 100618 . 10.1016/j.cpcardiol.2020.100618 32439197
Zenewicz L. A. ( 2018 ). IL-22: there is a gap in our knowledge. Immunohorizons 2 198 ? 207 . 10.4049/immunohorizons.1800006 31022687
Zhang J. Guan J. Niu X. Hu G. Guo S. Li Q. ( 2015 ). Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J. Transl. Med. 13 : 49 .
Zhang W. Li L. Liu J. Chen L. Zhou F. Jin T. ( 2020 ). The characteristics and predictive role of lymphocyte subsets in COVID-19 patients. Int. J. Infect. Dis. 99 92 ? 99 . 10.1016/j.ijid.2020.06.079 32758688
Zhang Y. Ding J. Ren S. Wang W. Yang Y. Li S. ( 2020 ). Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res. Ther. 11 : 207 .
Zhao L. Chen S. Yang P. Cao H. Li L. ( 2019 ). The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res. Ther. 10 : 182 .
Zou X. Chen K. Zou J. Han P. Hao J. Han Z. ( 2020 ). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14 185 ? 192 . 10.1007/s11684-020-0754-0 32170560
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.